Cabot (NYSE:CBT – Get Free Report) updated its FY 2026 earnings guidance on Monday. The company provided earnings per share guidance of 6.000-7.00 for the period, compared to the consensus earnings per share estimate of 7.610. The company issued revenue guidance of -.
Analyst Upgrades and Downgrades
A number of research analysts have recently weighed in on the stock. UBS Group set a $82.00 price target on shares of Cabot and gave the company a “neutral” rating in a report on Tuesday, August 5th. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a report on Wednesday, October 8th. Finally, Mizuho cut their price target on shares of Cabot from $90.00 to $88.00 and set an “outperform” rating on the stock in a report on Friday, October 3rd. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $85.00.
Get Our Latest Research Report on Cabot
Cabot Stock Performance
Cabot (NYSE:CBT – Get Free Report) last posted its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). Cabot had a net margin of 11.14% and a return on equity of 25.68%. The firm had revenue of $899.00 million during the quarter, compared to analyst estimates of $967.02 million. During the same quarter in the previous year, the business posted $1.80 earnings per share. The business’s quarterly revenue was down 10.2% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. On average, sell-side analysts anticipate that Cabot will post 7.57 EPS for the current year.
Insider Transactions at Cabot
In other Cabot news, CEO Sean D. Keohane sold 114,436 shares of the firm’s stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $79.28, for a total value of $9,072,486.08. Following the sale, the chief executive officer directly owned 361,518 shares in the company, valued at $28,661,147.04. This trade represents a 24.04% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 3.03% of the stock is owned by corporate insiders.
Institutional Trading of Cabot
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Sivia Capital Partners LLC acquired a new stake in Cabot in the 2nd quarter worth $279,000. Acadian Asset Management LLC acquired a new stake in Cabot in the 1st quarter worth $96,000. NewEdge Advisors LLC grew its position in Cabot by 2,559.5% in the 1st quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock worth $82,000 after purchasing an additional 947 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in Cabot by 344.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 813 shares of the specialty chemicals company’s stock worth $61,000 after purchasing an additional 630 shares during the last quarter. Finally, Geneos Wealth Management Inc. grew its position in Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares during the last quarter. 93.18% of the stock is currently owned by institutional investors and hedge funds.
About Cabot
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Further Reading
- Five stocks we like better than Cabot
- 3 REITs to Buy and Hold for the Long Term
- Amazon vs. Apple: Which Mag 7 Is the Better Buy?
- How to trade penny stocks: A step-by-step guide
- Is Starbucks Quietly Setting Up for a Major 2026 Comeback?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
